Scientific deep-dive

Does Zinc Help With Weight Loss? Honest Evidence Review

A 2026 meta-analysis of 41 randomized trials found zinc supplements had no clinically meaningful effect on weight. Here is what the trials, subgroups and safety data show, and who may need zinc for other reasons while losing weight.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
7 min read·14 citations

Zinc supplements do not appear to help with weight loss. A 2026 meta-analysis of 41 randomized trials found body weight rose slightly with zinc, by 0.68 kg (95% CI 0.33 to 1.03), while waist circumference fell by 1.03 cm (95% CI −1.92 to −0.13), and its authors called both effects small and not clinically significant[1]. The stronger case for zinc in a weight-loss setting is narrower: finding and correcting a shortfall in people at higher risk of one, such as after gastric bypass[10].

What the 2026 meta-analysis found

Salmani and colleagues searched the literature through October 2025 and pooled 41 randomized trials (44 effect sizes) of zinc supplements in adults[1]. BMI barely moved (0.02 kg/m²; p = 0.889). Fat mass (−0.08 kg; p = 0.794) and fat-free mass (0.41 kg; p = 0.669) did not change significantly either[1]. The only two significant results were the 0.68 kg weight increase and the 1.03 cm waist reduction, and they point in opposite directions[1]. The abstract does not say which trials fed which outcome, so that odd pairing can’t be explained from it.

The authors rated their certainty of evidence as very high for weight and waist, high for fat mass, moderate for fat-free mass, and low for BMI[1]. A high certainty rating here is not a point in zinc’s favor. As the authors put it, the strongest evidence corresponded to “minor changes,” which limits its clinical relevance[1]. In other words, the best-supported conclusion is that any effect on the scale is too small to matter.

Does the answer change by population?

Somewhat, though the subgroup signals are small and fragile. An earlier dose-response meta-analysis of 27 trials and 1,438 participants found no significant anthropometric change overall[2]. Its subgroups split: weight rose by 1.02 kg (95% CI 0.38 to 1.65) in three trials of people on hemodialysis and fell by 0.55 kg (95% CI −1.06 to −0.04) in five trials of 245 people with overweight or obesity who were otherwise healthy[2]. That second result looks encouraging, but it disappeared once the authors normalized for study duration[2].

In type 2 diabetes, a meta-analysis of 19 trials and 1,357 participants reported a BMI reduction of 0.53 kg/m² (95% CI −1.05 to −0.01; p = 0.046), with no significant change in body weight (−0.51 kg; 95% CI −1.99 to 0.97)[3]. The upper limit of that BMI interval sits just below zero, and the weight result did not reach significance.

Three meta-analyses of zinc supplements and body weight
AnalysisWho was studiedBody weightOther result
Salmani 202641 RCTs in adults+0.68 kg (95% CI 0.33 to 1.03)Waist −1.03 cm; no significant change in BMI, fat mass or fat-free mass
Abdollahi 202027 RCTs, 1,438 participantsNo significant change overall; +1.02 kg on hemodialysis; −0.55 kg with overweight or obesity, otherwise healthyThe overweight subgroup effect disappeared after normalizing for study duration
Khajeh 202419 RCTs, 1,357 people with type 2 diabetes−0.51 kg (95% CI −1.99 to 0.97), not significantBMI −0.53 kg/m² (95% CI −1.05 to −0.01)

A small trial with a positive result

The clearest positive result among these studies comes from a small trial. Khorsandi and colleagues randomized 40 people with obesity to 30 mg of zinc a day or placebo for 15 weeks, with both groups eating about 300 kcal below their estimated needs[4]. Reductions in weight, BMI, waist and hip circumference were significantly greater with zinc (P = 0.032, 0.025, 0.003 and 0.0001), and appetite scores, high-sensitivity CRP and HOMA-IR were lower[4]. The abstract gives P values without the size of the weight difference, and a 40-person trial cannot outweigh pooled evidence from dozens of others. It is a reason to run a larger trial and a poor reason to buy a supplement.

Leptin and inflammation: an appealing mechanism with thin support

Earlier studies suggested zinc might affect leptin, a fat-cell hormone involved in obesity[5]. The pooled clinical data do not back that up well. The 2026 analysis found no significant leptin effect (1.82 ng/mL; p = 0.165) and rated that evidence low certainty[1]. A 2019 meta-analysis of six trials also found no overall effect (0.74 ng/mL; 95% CI −1.39 to 2.87), with lower leptin only in subgroups of trials in women (−1.93 ng/mL) and trials lasting more than six weeks (−1.71 ng/mL)[5].

Inflammation is a somewhat better story, though it rests on small studies. In 40 young women with BMI of at least 25, 30 mg of zinc a day for eight weeks raised serum zinc by 15% and lowered hs-CRP (P = 0.03) and IL-6 (P = 0.006), with no such drop on placebo, while leptin and adiponectin did not differ with either treatment[6]. Lower inflammatory markers are not the same thing as weight loss, and that trial did not show any leptin benefit.

People with obesity may have lower zinc, but that does not settle cause

A meta-analysis of observational studies found lower serum zinc in adults with obesity than in controls (standardized mean difference −0.41; 95% CI −0.68 to −0.15), but no significant difference for adults with overweight (−0.09; 95% CI −0.27 to 0.09)[7]. Observational data like these can’t show that low zinc causes weight gain. Obesity could lower zinc levels, a third factor such as diet could drive both, or the link could run in some other way.

A different measure gives a different picture. In baseline data from 14,761 Chinese adults aged 30 to 79, higher urinary zinc was positively associated with waist circumference and general obesity[8]. That finding describes zinc leaving the body at one point in time, so it says little about whether taking zinc would help or harm. Neither study is a reason to supplement without a measured reason to do so.

Where zinc does matter: GLP-1 drugs and bariatric surgery

The more practical question is whether weight-loss treatment can leave someone short of zinc. A 2026 narrative review named zinc among the micronutrients of concern with GLP-1 and dual incretin drugs, which it tied to reduced food intake, lower dietary diversity and gastrointestinal intolerance, among other factors[9]. It also noted that most abnormalities reported so far are subclinical or indirect, and that risk concentrates in people with prior bariatric surgery, gastrointestinal disorders, poor baseline diet quality, older age or prolonged nausea and vomiting[9]. It called for prospective studies to define how often this happens[9]. None of the meta-analysis abstracts above reports a zinc trial in people on a GLP-1, so the add-on question is still open. Our guide to the best multivitamin on a GLP-1 covers the broader nutrient-gap question.

Surgery has firmer data. Across 12 before-and-after studies and 2,529 participants, serum zinc fell at 6 months (SMD −0.36; 95% CI −0.58 to −0.14) and 1 year (SMD −0.35; 95% CI −0.53 to −0.16) after bariatric surgery, with significant declines after Roux-en-Y and mini-gastric bypass but not sleeve gastrectomy[10]. Those authors recommended routine zinc monitoring and individualized supplementation in the first postoperative year[10].

Dieting alone looks less worrying, at least in one small study. In a 12-month weight-loss trial in young women, normal iron and zinc status was maintained during energy restriction, though only 36 participants completed it (21 on higher protein, 15 on lower protein)[11].

Dose and safety

The recommended daily allowance is 11 mg for adult men and 8 mg for women aged 19 and over who are not pregnant or lactating[13]. The 30 mg daily dose used in the Khorsandi and Kim trials is well beyond that[4][6]. A 2024 review gives upper limits of 25 mg a day from the European Food Safety Authority and 40 mg a day, which it attributes to the FDA[14], so that trial dose exceeds the European limit.

Large doses can cause diarrhea, abdominal cramps and vomiting, and long-term excess can lead to copper, iron or magnesium deficiency[13]. The serious version is rare but easy to miss. A 2026 systematic review collected 37 cases of zinc-induced blood problems, with reported doses from about 50 mg to more than 1,500 mg of elemental zinc a day, most often from oral supplements, denture adhesive creams or swallowed coins[12]. Anemia was present in nearly all cases, serum copper was low in every patient, and the bone marrow findings often led to an initial misdiagnosis of myelodysplastic syndrome[12]. Most cases recovered after zinc was stopped and copper was given, but neurological symptoms improved more slowly and sometimes incompletely[12]. Case collections can’t tell us how common this is.

Low zinc can itself cause poor appetite, hair loss and taste problems[13], which overlap with complaints people report on a GLP-1. Our review of metallic taste on GLP-1 drugs looks at that overlap. For readers comparing minerals, our magnesium review covers a separate question about which form to use.

What to raise with a prescriber

  • Whether your history puts you in a higher-risk group, particularly gastric bypass, a gastrointestinal disorder, or prolonged nausea and vomiting on a GLP-1[9][10].
  • Whether a zinc test makes sense before you start a supplement, given that the case for zinc rests on correcting a shortfall and not on a weight-loss effect[1][9].
  • The total zinc you get from all sources, including multivitamins, immune products and denture creams, and whether copper should be checked if you take higher doses for long periods[12][13].

Frequently Asked Questions

The evidence says no in any meaningful way. A 2026 meta-analysis of 41 randomized trials found a small 0.68 kg weight increase with zinc and a 1.03 cm waist reduction, and its authors described both as not clinically significant. BMI and fat mass did not change significantly.
The 2026 meta-analysis found an average gain of 0.68 kg, which is small, and an earlier analysis found a 1.02 kg gain in people on hemodialysis. BMI and fat mass did not change significantly in the 2026 analysis, and the authors did not consider the effects clinically significant. Weight gain is not a strong reason to avoid zinc you need for a diagnosed shortfall.
There is no established rule that everyone on a GLP-1 needs extra zinc. A 2026 narrative review listed zinc among nutrients of concern, mainly because people eat less, and said most reported abnormalities so far are subclinical or indirect. People with prior bariatric surgery, gastrointestinal disorders, poor diet quality or prolonged vomiting have more reason to ask a prescriber about nutrient testing.
The recommended daily amount is 11 mg for adult men and 8 mg for most adult women. One 2024 review lists upper limits of 25 mg a day from European regulators and 40 mg a day attributed to the FDA. Reported cases of zinc-induced copper deficiency and anemia involved roughly 50 mg a day or more, with exposure lasting weeks to years.

References

  1. 1.Salmani M, Karimi M, Asbaghi O, Bagheri R, Nikbaf-Shandiz M, Bakhtiary F, Goudarzi K, Kazemi K, Shouhani Z, Setayesh L, Haghighat N, Ashtary-Larky D. Effects of Zinc Supplementation on Anthropometric Indices and Adipokines in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Biol Trace Elem Res. 2026. PMID: 41617950.
  2. 2.Abdollahi S, Toupchian O, Jayedi A, Meyre D, Tam V, Soltani S. Zinc Supplementation and Body Weight: A Systematic Review and Dose-Response Meta-analysis of Randomized Controlled Trials. Adv Nutr. 2020. PMID: 31504083.
  3. 3.Khajeh M, Hassanizadeh S, Pourteymour Fard Tabrizi F, Hassanizadeh R, Vajdi M, Askari G. Effect of Zinc Supplementation on Lipid Profile and Body Composition in Patients with Type 2 Diabetes Mellitus: A GRADE-Assessed Systematic Review and Dose-Response Meta-analysis. Biol Trace Elem Res. 2024. PMID: 38224402.
  4. 4.Khorsandi H, Nikpayam O, Yousefi R, Parandoosh M, Hosseinzadeh N, Saidpour A, Ghorbani A. Zinc supplementation improves body weight management, inflammatory biomarkers and insulin resistance in individuals with obesity: a randomized, placebo-controlled, double-blind trial. Diabetol Metab Syndr. 2019. PMID: 31827626.
  5. 5.Khorshidi M, Zarezadeh M, Sadeghi A, Teymouri A, Emami MR, Kord-Varkaneh H, Aryaeian N, Rahmani J, Mousavi SM. The Effect of Zinc Supplementation on Serum Leptin Levels: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Horm Metab Res. 2019. PMID: 31408896.
  6. 6.Kim J, Ahn J. Effect of zinc supplementation on inflammatory markers and adipokines in young obese women. Biol Trace Elem Res. 2014. PMID: 24402636.
  7. 7.Gu K, Xiang W, Zhang Y, Sun K, Jiang X. The association between serum zinc level and overweight/obesity: a meta-analysis. Eur J Nutr. 2019. PMID: 30542939.
  8. 8.Zhong J, Zhang L, Wu X, Xu Z, Cheng S, Long T, Yang T, Hong F. Sex-specific associations of urinary zinc, iron, and zinc-to-iron ratio with obesity indicators and phenotypes. Eur J Nutr. 2026. PMID: 42530649.
  9. 9.Simancas-Racines D, Campuzano-Donoso M, Rossetti G, Cobellis L, Pilone V, Fascì-Spurio F, Jima Gavilanes D, Soria C, Reytor-González C, Schiavo L. Micronutrient risk with GLP-1 receptor and dual incretin agonists in obesity: Mechanistic pathways, clinical signals, and a monitoring framework. Obes Pillars. 2026. PMID: 42382663.
  10. 10.Zhu C, Liu W. Zinc status following different bariatric procedures: systematic review and meta-analysis. Ann Med. 2026. PMID: 41475404.
  11. 11.Cheng HL, Griffin HJ, Bryant CE, Rooney KB, Steinbeck KS, O'Connor HT. Impact of diet and weight loss on iron and zinc status in overweight and obese young women. Asia Pac J Clin Nutr. 2013. PMID: 24231018.
  12. 12.Dutta A, Chaudhary V, Kumari S, Rohita, Sharma KK, Pal B. Zinc-Induced Hematologic Toxicities: A Systematic Review of Descriptive Studies. Biol Trace Elem Res. 2026. PMID: 42087025.
  13. 13.MedlinePlus, National Library of Medicine. Zinc in diet. MedlinePlus Medical Encyclopedia. 2025. https://medlineplus.gov/ency/article/002416.htm
  14. 14.Schoofs H, Schmit J, Rink L. Zinc Toxicity: Understanding the Limits. Molecules. 2024. PMID: 38999082.

Best Multivitamin on a GLP-1: Covering Nutrient Gaps (incl. Women on Tirzepatide) (2026)

Eating much less on a GLP-1 makes nutrient targets harder to hit. Whether a multivitamin makes sense, the nutrients easiest to fall short on, and the iron/folate/calcium angle for women on tirzepatide.

7 min read

Degenerative Disc Disease and Body Weight: What MRI Studies Show

Does body weight cause degenerative disc disease? MRI and genetic studies on BMI and lumbar disc degeneration, why scans often show it without pain, what happens to discs and back pain after major weight loss, and what is known about GLP-1 drugs.

10 min read

Dupuytren's Contracture, Diabetes and Weight: What the Evidence Shows

Dupuytren's contracture is about three times more likely with diabetes, and high blood sugar looks causal, but higher BMI is linked to lower risk. What the evidence says about weight loss, alcohol, needle, collagenase and surgical treatment, and the missing GLP-1 data.

10 min read

DVT and Blood Clots with Obesity: Estrogen, Surgery and What GLP-1 Data Show

Deep vein thrombosis and pulmonary embolism symptoms, how obesity raises clot risk and multiplies the risk from the pill and oral HRT, the surgical window, what weight loss changes, and the conflicting trial and real-world evidence on GLP-1 drugs and blood clots.

11 min read

Endoscopic (Non-Surgical) Weight-Loss Options: ESG, Balloon, and GLP-1 Compared

Endoscopic options sit between GLP-1s and surgery. ESG produced 13.6% weight loss at one year in the MERIT trial, holding near 16% at five years, and the intragastric balloon gives about 11 to 13% in pooled data. Both are compared with GLP-1s and surgery.

12 min read

Endoscopic Sleeve Gastroplasty (ESG): The Evidence vs GLP-1s and Surgery

ESG, an incisionless stomach-tightening procedure, produced about 13.6% weight loss at 52 weeks in the MERIT trial, roughly on par with semaglutide (14.9%), below tirzepatide (20.9%) and well below surgery. Also covers safety, cost, reversibility, and the GLP-1 comparison.

12 min read

Where to get GLP-1 safely: vetted online providers

Vetted telehealth providers that prescribe online. We compare pricing, form, and states served.

No insurance needed · vetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

7.7

Ro

FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help

Read full review →

From $149/mo

+ required membership

Get started →
8.3

Collective

The lowest flat medication price if you can absorb an annual membership fee

Read full review →

From $59/mo

+ required membership

Get started →
8.3

CoreAge Rx

Lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

Read full review →

From $79/mo

“starting at” price

Get started →

About this analysis

Weight Loss Rankings is an independent editorial publication. Our provider dataset is verified directly against each provider's website and updated continuously. Read our full methodology →